Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Mo-Ni/SiO2 catalyst enables high-yield synthesis of O-methyl caprolactam imide. Reduces waste and enhances supply chain reliability for pharmaceutical intermediate manufacturing.
Novel two-step route eliminates dimer byproducts, achieving >99% purity. Ideal for reliable API intermediate supply chains seeking cost reduction.
Patent CN114277023A details a novel biocatalytic route using recombinant E. coli and ion exchange resin for >99.99% purity nicotinamide.
Patent CN103613562B offers eco-friendly pramipexole synthesis reducing chromium pollution and costs for reliable supply chain partners globally seeking high purity.
Patent CN105130726A reveals a phosphorous acid-mediated route for cinnamaldehyde. Offers cost reduction and supply chain reliability for pharmaceutical and flavor manufacturers globally.
Patent CN116323522B reveals a base-free ruthenium catalyst enabling stable, scalable production of optically active secondary alcohols with superior cost efficiency.
Patent CN102753537B details a safer Rivaroxaban synthesis route avoiding hydrobromic acid, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN106565620A reveals a novel gamma-Fe2O3 catalyst for tetrazole synthesis, offering high purity, cost reduction, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN107382877A details a mild synthetic route for Vitamin B1 intermediates. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101429230B reveals resin-based purification achieving over 99% purity. This method reduces impurities for injectable applications and offers significant supply chain cost advantages.
Patent CN111116446B details a green, scalable synthesis of 3-substituted-1H-pyrrole intermediates, offering cost reduction in API manufacturing and high purity.
Patent CN102174006A details a novel chiral hydroxyl amide synthesis using copper acetate, offering high conversion rates for pharmaceutical intermediate manufacturing.
Novel Ru-phosphine-nitrogen complexes enable efficient ketone reduction. Enhances supply chain reliability and reduces manufacturing costs for chiral intermediates.
Patent CN113308704B reveals a green electrooxidative route for 6-methoxy-2-naphthylglyoxylate. This method eliminates cryogenic conditions and toxic oxidants for cost-effective API production.
Patent CN104974088B reveals WO3/TiO2 catalyzed oxidation. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN101245067B reveals a novel Entecavir synthesis route improving yield to 45.3% and purity to 99.7%, offering significant cost reduction in antiviral drug manufacturing.
Discover the patented preparation method for monocyclic beta-lactam antibiotic intermediates. Enhance your supply chain with high-purity quinoxaline derivatives and scalable processes.
Novel catalyst-free synthesis of spiro-gamma-lactams via Ugi reaction. Reduces metal contamination risks and simplifies purification for pharmaceutical intermediates.
Novel Pd-catalyzed asymmetric synthesis for spirobarbituric acid-epoxyhexane intermediates. High yield, mild conditions, and scalable supply chain solutions for pharma.
Patent CN102199103A details an improved oxidative coupling method for L-thyroxine sodium, enhancing yield and purity while reducing manufacturing costs for API intermediates.